159 related articles for article (PubMed ID: 3927916)
1. The effect of ring-fluorination on the rate of O-methylation of dihydroxyphenylalanine (DOPA) by catechol-O-methyltransferase: significance in the development of 18F-PETT scanning agents.
Creveling CR; Kirk KL
Biochem Biophys Res Commun; 1985 Aug; 130(3):1123-31. PubMed ID: 3927916
[TBL] [Abstract][Full Text] [Related]
2. Metabolism and blood-brain clearance of L-3,4-dihydroxy-[3H]phenylalanine ([3H]DOPA) and 6-[18F]fluoro-L-DOPA in the rat.
Cumming P; Ase A; Diksic M; Harrison J; Jolly D; Kuwabara H; Laliberté C; Gjedde A
Biochem Pharmacol; 1995 Sep; 50(7):943-6. PubMed ID: 7575677
[TBL] [Abstract][Full Text] [Related]
3. Substrate stereospecificity and selectivity of catechol-O-methyltransferase for DOPA, DOPA derivatives and alpha-substituted catecholamines.
Gordonsmith RH; Raxworthy MJ; Gulliver PA
Biochem Pharmacol; 1982 Feb; 31(3):433-7. PubMed ID: 6803810
[TBL] [Abstract][Full Text] [Related]
4. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
Psylla M; Günther I; Antonini A; Vontobel P; Reist HW; Zollinger A; Leenders KL
Brain Res; 1997 Aug; 767(1):45-54. PubMed ID: 9365014
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vivo metabolism of 6-[18F]fluoro-L-dopa and [3H]L-dopa in rats.
Melega WP; Luxen A; Perlmutter MM; Nissenson CH; Phelps ME; Barrio JR
Biochem Pharmacol; 1990 Jun; 39(12):1853-60. PubMed ID: 2112915
[TBL] [Abstract][Full Text] [Related]
6. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
Ishikawa T; Dhawan V; Chaly T; Robeson W; Belakhlef A; Mandel F; Dahl R; Margouleff C; Eidelberg D
J Cereb Blood Flow Metab; 1996 Sep; 16(5):854-63. PubMed ID: 8784230
[TBL] [Abstract][Full Text] [Related]
7. Developmental changes in the activities of aromatic amino acid decarboxylase and catechol-O-methyl transferase in the porcine brain: a positron emission tomography study.
Brust P; Walter B; Hinz R; Füchtner F; Müller M; Steinbach J; Bauer R
Neurosci Lett; 2004 Jul; 364(3):159-63. PubMed ID: 15196667
[TBL] [Abstract][Full Text] [Related]
8. Phenol ionization in dopa determines the site of methylation by catechol-O-methyltransferase.
Firnau G; Sood S; Pantel R; Garnett S
Mol Pharmacol; 1981 Jan; 19(1):130-3. PubMed ID: 6782443
[No Abstract] [Full Text] [Related]
9. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography in drug evaluation: influence of three different catechol-O-methyltransferase inhibitors on metabolism of [NCA] 6-[18F]fluoro-L-dopa in rhesus monkey.
Günther I; Psylla M; Reddy GN; Antonini A; Vontobel P; Reist HW; Zollinger A; Nickles RJ; Beer HF; Schubiger PA
Nucl Med Biol; 1995 Oct; 22(7):921-7. PubMed ID: 8547890
[TBL] [Abstract][Full Text] [Related]
11. [18F]fluoro-L-dopa for the in vivo study of intracerebral dopamine.
Firnau G; Garnett ES; Chirakal R; Sood S; Nahmias C; Schrobilgen G
Int J Rad Appl Instrum A; 1986; 37(8):669-75. PubMed ID: 3021668
[TBL] [Abstract][Full Text] [Related]
12. Salvianolic acid B as a substrate and weak catechol-O-methyltransferase inhibitor in rats.
Qi Q; Cao L; Li F; Wang H; Liu H; Hao H; Hao K
Xenobiotica; 2015; 45(9):820-7. PubMed ID: 25869243
[TBL] [Abstract][Full Text] [Related]
13. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.
Cumming P; Gjedde A
Synapse; 1998 May; 29(1):37-61. PubMed ID: 9552174
[TBL] [Abstract][Full Text] [Related]
14. Production of 6-[18F]fluoro-L-dopa and its metabolism in vivo--a critical review.
Luxen A; Guillaume M; Melega WP; Pike VW; Solin O; Wagner R
Int J Rad Appl Instrum B; 1992 Feb; 19(2):149-58. PubMed ID: 1601668
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.
Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME
J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385
[TBL] [Abstract][Full Text] [Related]
16. Behavior of fluorinated analogs of L-(3,4-dihydroxyphenyl)alanine and L-threo-(3,4-dihydroxyphenyl)serine as substrates for Dopa decarboxylase.
Borri Voltattorni C; Bertoldi M; Bianconi S; Deng WP; Wong K; Kim I; Herbert B; Kirk KL
Biochem Biophys Res Commun; 2002 Jul; 295(1):107-11. PubMed ID: 12083775
[TBL] [Abstract][Full Text] [Related]
17. 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism and positron emission tomography after catechol-O-methyltransferase inhibition in normal and hemiparkinsonian monkeys.
Miletich RS; Comi G; Bankiewicz K; Plunkett R; Adams R; Di Chiro G; Kopin IJ
Brain Res; 1993 Oct; 626(1-2):1-13. PubMed ID: 8281420
[TBL] [Abstract][Full Text] [Related]
18. Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.
Cumming P; Boyes BE; Martin WR; Adam M; Ruth TJ; McGeer EG
Biochem Pharmacol; 1987 Aug; 36(15):2527-31. PubMed ID: 3111485
[TBL] [Abstract][Full Text] [Related]
19. Regional brain kinetics of 6-fluoro-(beta-11C)-L-dopa and (beta-11C)-L-dopa following COMT inhibition. A study in vivo using positron emission tomography.
Hartvig P; Lindner KJ; Tedroff J; Bjurling P; Hörnfelt K; Långström B
J Neural Transm Gen Sect; 1992; 87(1):15-22. PubMed ID: 1536715
[TBL] [Abstract][Full Text] [Related]
20. Rat liver catechol-O-methyltransferase kinetics and assay methodology.
Borges N; Vieira-Coelho MA; Parada A; Soares-da-Silva P
J Enzyme Inhib; 1998 Sep; 13(6):473-83. PubMed ID: 9825310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
